Patent details

Basic Information

Publication number:

EP3348569

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181534389

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PAN ELR+ CXC CHEMOKINE ANTIBODIES

French Title of Invention:

BAC D'ANTICORPS DE CHIMIOKINES ELR+CXC

German Title of Invention:

CHEMOKINE PAN-ELR+-CXC-ANTIKÖRPER

SPC Number:

Dates

Filing date:

05/03/2014

Grant date:

27/11/2019

EP Publication Date:

18/07/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/11/2019

EP B1 Publication Date:

27/11/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/03/2020

Expiration date:

05/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/11/2019

 

 

Name:

ELI LILLY AND COMPANY

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

1

Name:

Beidler, Catherine Brautigam

Address:

United States (US)

2

Name:

Strifler, Beth Ann

Address:

United States (US)

3

Name:

Witcher, Derek Ryan

Address:

United States (US)

4

Name:

Boyles, Jeffrey Streetman

Address:

United States (US)

5

Name:

Kikly, Kristine Kay

Address:

United States (US)

Priority

Priority Number:

201361792800 P

Priority Date:

15/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/18; C07K 16/24;

Publication

European Patent Bulletin

Issue number:

201948

Publication date:

27/11/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages